Back to top
more

Cronos Group (CRON)

(Real Time Quote from BATS)

$2.41 USD

2.41
501,754

+0.03 (1.26%)

Updated Jul 12, 2024 02:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 250)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

Do Options Traders Know Something About Cronos (CRON) Stock We Don't?

Investors need to pay close attention to Cronos (CRON) stock based on the movements in the options market lately.

The Zacks Analyst Blog Highlights: Tilray, Canopy Growth, Cronos and ETFMG Alternative Harvest

The Zacks Analyst Blog Highlights: Tilray, Canopy Growth, Cronos and ETFMG Alternative Harvest

Neena Mishra headshot

Why Marijuana Stocks & ETF Soared Today

Pot stocks soared today as Jeff Sessions' exit and midterm elections have created a more favorable political environment for the industry.

Cronos (CRON) to Report Q3 Earnings: What's in the Cards?

Investors will focus on pipeline progress and updates when Cronos (CRON) reports third-quarter results.

Analysts Estimate Cronos Group (CRON) to Report a Decline in Earnings: What to Look Out for

Cronos (CRON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights: Tilray, Cronos, Canopy Growth, GW Pharmaceuticals and Constellation Brands

The Zacks Analyst Blog Highlights: Tilray, Cronos, Canopy Growth, GW Pharmaceuticals and Constellation Brands

Sweta Killa headshot

Marijuana ETF Enters Bear Territory: What Lies Ahead?

Despite entering into bear territory, the cannabis ETF is up more than 24% over the past three months and the outlook remains bright.

Marijuana Stocks Plummet to Record Low: What's Next?

Legalization has long been considered a boon for the marijuana industry.

Neena Mishra headshot

Canada Legalizes Marijuana: Stocks & ETF in Focus

Canada legalized recreational pot today but it's "sell the news" event for pot stocks that have seen astronomical gains recently.

Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Cronos Group (CRON) closed at $11.52, marking a -1.87% move from the previous day.

Cronos Group (CRON) Dips More Than Broader Markets: What You Should Know

Cronos Group (CRON) closed at $9.70 in the latest trading session, marking a -0.82% move from the prior day.

Neena Mishra headshot

Pot Stocks & ETF: Risks and Rewards

Here is what investors need to know about risks and rewards of investing in the emerging marijuana industry.

    Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know

    In the latest trading session, Cronos Group (CRON) closed at $10.94, marking a -1.89% move from the previous day.

      Ryan McQueeney headshot

      Wall Street's Reefer Madness, Micron Earnings, & More Stock News

      Ryan McQueeney and Maddy Johnson discuss the performance of Netflix and other streaming services at the Emmys. The team also chat about the alleged criminal probe facing Elon Musk and Tesla. Later, they discuss marijuana stocks and recap Micron's latest earnings report.

        Rajani Lohia headshot

        Know How Beverage Stocks Will Gain From Shift to Marijuana

        Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.

          Ryan McQueeney headshot

          Tesla Bull Sells (and Buys Again?) & Dow Rallies Near Highs | Free Lunch

          Ryan McQueeney highlights the Dow's rally toward all-time highs on the back of strength from financial stocks. He also touches on news related to marijuana producers and reported activist interest in casino giant MGM. Later, the host calls Brian Bolan, a noted Tesla bull, to discuss a major shift in his sentiment for the electric car company.

            Ryan McQueeney headshot

            Marijuana Stocks Soar Again As Wall Street Eyes U.S. Imports

            Shares of several popular Canadian marijuana producers--including Tilray (TLRY), Canopy Growth (CGC), and Cronos Group (CRON)--were surging once again on Wednesday as Wall Street grows ever-more bullish on the prospects of legalization and U.S. imports.

              Ryan McQueeney headshot

              Will Disruptive Technology Play a Role in the Marijuana Industry?

              Ryan McQueeney discusses the intersection of disruptive technology and the budding marijuana industry, ultimately concluding that investors should remember what they've learned about investing in other forms of new tech as it becomes a bigger factor in the cannabis business.

                Neena Mishra headshot

                Marijuana Stocks and ETF: What Investors Need to Know

                Pot stocks are hot but also very volatile, here is what investors need to know.

                  The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW

                  The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW

                    Sweta Killa headshot

                    ETFs & Stocks to Tap Marijuana Boom

                    Investors seeking to tap the ongoing green rush may consider these ETFs and stocks.

                      Cronos Group (CRON) Outpaces Stock Market Gains: What You Should Know

                      Cronos Group (CRON) closed at $12.10 in the latest trading session, marking a +0.83% move from the prior day.

                        Company News For Sept 5, 2018

                        Companies In The News are: ORIG,SWN,CRON,WPP

                          Sweta Killa headshot

                          5 Best Stocks of the Top ETF of August

                          Cannabis-related ETFMG Alternative Harvest ETF (MJ) is the best-performing ETF of August, gaining 22.5% and attracting $22 million in AUM.

                            Benjamin Rains headshot

                            What Investors Need to Know About Investing In Marijuana Stocks

                            Marijuana has come a long way since California legalized cannabis for medicinal use back in 1996. Today, the industry and marijuana look to be on the cusp of unprecedented acceptance, with major international giants investing billions into publicly traded cannabis companies. So let's take a look at what investors need to know about the marijuana industry and how to invest in the future of pot.